While many existing solutions rely on traditional remote monitoring for disease management, ISHI Health stands out with its innovative and unique AI-driven approach. Through our collaboration with Mayo Clinic, ISHI provides precision care to patients with heart failure and heart disease. The virtual care program utilizes a platform that analyzes patient biometric data collected from a variety of external and implantable cardiac sensors across the cardiac risk spectrum. This allows ISHI to tailor care to each patient’s unique cardiac profile, biometric data, and symptoms.

At the core of ISHI’s strategy is a collaborative partnership with a patient’s primary care physician that enables care teams to deliver quality heart failure care in the community. ISHI’s turnkey, bolt-on model facilitates a free-of-care model and provides rapid access to top-tier heart failure specialty care. This approach underscores his ISHI’s commitment to ensuring high-quality, proactive care for patients that aligns with the interests of healthcare providers, value-based healthcare organizations, and payers. ISHI currently operates with the following provider groups: California More markets will be announced soon.

Dr. Ajay Srivastava, Advanced Heart Failure Cardiologist and Founder of ISHI Health, emphasized the company’s dedication to revolutionizing the delivery of cardiac care with a patient-first approach. I am. Through the integration of technology and AI, we can offer our patients unprecedented convenience and proactive care, ensuring better outcomes and an enhanced patient experience. ”

ISHI goes beyond traditional treatment approaches by providing proactive recommendations customized to each patient’s needs. These recommendations may include personalized medication coordination and empowerment strategies delivered via SMS, such as educational resources and medication reminders. If a patient’s data indicates an increased risk, a dedicated heart failure care team will intervene immediately and work closely with the primary care physician team. ISHI’s integrated approach optimizes patient outcomes by coordinating care between various medical team members and ensures comprehensive support throughout the patient’s treatment journey.

ISHI’s commitment to providing high-quality heart failure care in rural and suburban areas was recognized with the prestigious AWS Health Equity Award, a non-dilutive funding grant. This honor highlights his ISHI’s dedication to addressing health disparities and providing excellent care to underserved communities outside of urban centers.

“At TDV, we are dedicated to identifying advanced capabilities that improve patient outcomes and experiences. ISHI stands out by integrating AI, virtual and remote capabilities, benefiting a wide range of patients. “We are delivering an innovative hybrid care solution with the potential to transform heart failure into a commonly coexisting cardiometabolic condition in this patient population,” said TDV investor Susie Yun. Masu. “We are excited to join this journey, contributing our expertise and valuable resources in virtual first care and helping advance ISHI’s mission to transform cardiac care.”

With recently secured funding, ISHI is in a position to increase its capabilities. The company aims to expand its clinical operations, forge partnerships with more healthcare provider groups and enter new markets over the next year. ISHI is committed to showcasing superior clinical outcomes and patient experiences, as well as collaborating with payers on value-based care initiatives tailored to heart failure and complex cardiac patient populations.

About ISHI Health:
ISHI Health is an AI-driven virtual clinic focused on heart failure and complex heart disease care. ISHI provides specialized, convenient, and cost-effective heart failure care by integrating connected devices, AI algorithms, and specialized care teams. We aim to improve health outcomes, enhance the patient experience and collaborate with patients’ care teams.

For more information, please visit www.ishi.health.

About TDV:
TDV is the digital health venture arm of Takeda Pharmaceutical Company, a leading values-based, R&D-driven biopharmaceutical company. Japan, guided by our commitment to patients, people and the planet. Takeda Digital Ventures invests in companies that use digital technology to improve outcomes and experiences across patient care. We take a patient-first approach and invest only in companies that reflect Takeda’s values.

For more information, please visit https://takeda.info/tdv.

Media inquiries:
[email protected]

SOURCE ISHI Health, Inc.